1. Abbadi M, Morin C.. (1999) On the analogy between forskolin and D-glucose., 9 (13): [PMID:10406641] [10.1016/s0960-894x(99)00270-x] |
2. Khandelwal Y, Rajeshwari K, Rajagopalan R, Swamy L, Dohadwalla AN, de Souza NJ, Rupp RH.. (1988) Cardiovascular effects of new water-soluble derivatives of forskolin., 31 (10): [PMID:3172122] [10.1021/jm00118a002] |
3. Chang C, Kuo S, Lin Y, Wang J, Huang L.. (2001) Benzyloxybenzaldehyde analogues as novel adenylyl cyclase activators., 11 (15): [PMID:11454460] [10.1016/s0960-894x(01)00353-5] |
4. Robbins JD, Boring DL, Tang WJ, Shank R, Seamon KB.. (1996) Forskolin carbamates: binding and activation studies with type I adenylyl cyclase., 39 (14): [PMID:8709105] [10.1021/jm960191+] |
5. Robbins JD, Laurenza A, Kosley RW, O'Malley GJ, Spahl B, Seamon KB.. (1991) (Aminoalkyl)carbamates of forskolin: intermediates for the synthesis of functionalized derivatives of forskolin with different specificities for adenylyl cyclase and the glucose transporter., 34 (11): [PMID:1956039] [10.1021/jm00115a009] |
6. Lam T, Ling T, Chowdhury C, Chao TH, Bahjat FR, Lloyd GK, Moldawer LL, Palladino MA, Theodorakis EA.. (2003) Synthesis of a novel family of diterpenes and their evaluation as anti-inflammatory agents., 13 (19): [PMID:12951096] [10.1016/s0960-894x(03)00669-3] |
7. McNeal ET, Lewandowski GA, Daly JW, Creveling CR.. (1985) [3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs., 28 (3): [PMID:2579237] [10.1021/jm00381a019] |
8. Martínez-Esparza J, Oficialdegui AM, Pérez-Silanes S, Heras B, Orús L, Palop JA, Lasheras B, Roca J, Mourelle M, Bosch A, Del Castillo JC, Tordera R, Del Río J, Monge A.. (2001) New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants., 44 (3): [PMID:11462981] [10.1021/jm001059j] |
9. Marivingt-Mounir C, Norez C, Dérand R, Bulteau-Pignoux L, Nguyen-Huy D, Viossat B, Morgant G, Becq F, Vierfond JM, Mettey Y.. (2004) Synthesis, SAR, crystal structure, and biological evaluation of benzoquinoliziniums as activators of wild-type and mutant cystic fibrosis transmembrane conductance regulator channels., 47 (4): [PMID:14761197] [10.1021/jm0308848] |
10. Wen CC, Kuo YH, Jan JT, Liang PH, Wang SY, Liu HG, Lee CK, Chang ST, Kuo CJ, Lee SS, Hou CC, Hsiao PW, Chien SC, Shyur LF, Yang NS.. (2007) Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus., 50 (17): [PMID:17663539] [10.1021/jm070295s] |
11. Katona BW, Cummins CL, Ferguson AD, Li T, Schmidt DR, Mangelsdorf DJ, Covey DF.. (2007) Synthesis, characterization, and receptor interaction profiles of enantiomeric bile acids., 50 (24): [PMID:17963371] [10.1021/jm0707931] |
12. Swanson SM, Jiang JX, Chang YS, De Souza NJ, Pezzuto JM.. (1988) A rapid and sensitive bioassay involving cultured rat glioma cells to screen for substances capable of elevating intracellular cyclic AMP concentration., 51 (5): [PMID:2849641] [10.1021/np50059a019] |
13. Sweetnam PM, Caldwell L, Lancaster J, Bauer C, McMillan B, Kinnier WJ, Price CH.. (1993) The role of receptor binding in drug discovery., 56 (4): [PMID:8496700] [10.1021/np50094a001] |
14. Chen J, Hammell DC, Spry M, D'Orazio JA, Stinchcomb AL.. (2009) In vitro skin diffusion study of pure forskolin versus a forskolin-containing Plectranthus barbatus root extract., 72 (4): [PMID:19281221] [10.1021/np800541k] |
15. Williams A, Sarkar S, Cuddon P, Ttofi EK, Saiki S, Siddiqi FH, Jahreiss L, Fleming A, Pask D, Goldsmith P, O'Kane CJ, Floto RA, Rubinsztein DC.. (2008) Novel targets for Huntington's disease in an mTOR-independent autophagy pathway., 4 (5): [PMID:18391949] [10.1038/nchembio.79] |
16. Diamandis P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG, Tyers M, Dirks PB.. (2007) Chemical genetics reveals a complex functional ground state of neural stem cells., 3 (5): [PMID:17417631] [10.1038/nchembio873] |
17. Hutt DM, Herman D, Rodrigues AP, Noel S, Pilewski JM, Matteson J, Hoch B, Kellner W, Kelly JW, Schmidt A, Thomas PJ, Matsumura Y, Skach WR, Gentzsch M, Riordan JR, Sorscher EJ, Okiyoneda T, Yates JR, Lukacs GL, Frizzell RA, Manning G, Gottesfeld JM, Balch WE.. (2010) Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis., 6 (1): [PMID:19966789] [10.1038/nchembio.275] |
18. PubChem BioAssay data set, |
19. PubChem BioAssay data set, |
20. Hayashi S, Nakata E, Morita A, Mizuno K, Yamamura K, Kato A, Ohashi K.. (2010) Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships., 18 (21): [PMID:20875743] [10.1016/j.bmc.2010.07.034] |
21. PubChem BioAssay data set, |
22. PubChem BioAssay data set, |
23. Wang EJ, Casciano CN, Clement RP, Johnson WW.. (2001) Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors., 289 (1): [PMID:11716514] [10.1006/bbrc.2001.6000] |
24. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
25. PubChem BioAssay data set, |
26. Brunhofer G, Fallarero A, Karlsson D, Batista-Gonzalez A, Shinde P, Gopi Mohan C, Vuorela P.. (2012) Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine., 20 (22): [PMID:23062825] [10.1016/j.bmc.2012.09.040] |
27. Kirby RW, Martelli A, Calderone V, McKay NG, Lawson K.. (2013) Large conductance Ca(2+)-activated K(+) channel (BKCa) activating properties of a series of novel N-arylbenzamides: Channel subunit dependent effects., 21 (14): [PMID:23707646] [10.1016/j.bmc.2013.05.003] |
28. De Bruyn T, van Westen GJ, Ijzerman AP, Stieger B, de Witte P, Augustijns PF, Annaert PP.. (2013) Structure-based identification of OATP1B1/3 inhibitors., 83 (6): [PMID:23571415] [10.1124/mol.112.084152] |
29. PubChem BioAssay data set, |
30. PubChem BioAssay data set, |
31. D'Amore C, Di Leva FS, Sepe V, Renga B, Del Gaudio C, D'Auria MV, Zampella A, Fiorucci S, Limongelli V.. (2014) Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors., 57 (3): [PMID:24387325] [10.1021/jm401873d] |
32. Shukla SJ, Sakamuru S, Huang R, Moeller TA, Shinn P, Vanleer D, Auld DS, Austin CP, Xia M.. (2011) Identification of clinically used drugs that activate pregnane X receptors., 39 (1): [PMID:20966043] [10.1124/dmd.110.035105] |
33. Gertzen CG, Spomer L, Smits SH, Häussinger D, Keitel V, Gohlke H.. (2015) Mutational mapping of the transmembrane binding site of the G-protein coupled receptor TGR5 and binding mode prediction of TGR5 agonists., 104 [PMID:26435512] [10.1016/j.ejmech.2015.09.024] |
34. Niu B, Ke CQ, Li BH, Li Y, Yi Y, Luo Y, Shuai L, Yao S, Lin LG, Li J, Ye Y.. (2017) Cucurbitane Glucosides from the Crude Extract of Siraitia grosvenorii with Moderate Effects on PGC-1α Promoter Activity., 80 (5): [PMID:28448136] [10.1021/acs.jnatprod.6b01086] |
35. Wilson KJ, Xiao J, Chen CZ, Huang Z, Agoulnik IU, Ferrer M, Southall N, Hu X, Zheng W, Xu X, Wang A, Myhr C, Barnaeva E, George ER, Agoulnik AI, Marugan JJ.. (2018) Optimization of the first small-molecule relaxin/insulin-like family peptide receptor (RXFP1) agonists: Activation results in an antifibrotic gene expression profile., 156 [PMID:30006176] [10.1016/j.ejmech.2018.06.008] |
36. Burra S, Voora V, Rao CP, Vijay Kumar P, Kancha RK, David Krupadanam GL.. (2017) Synthesis of novel forskolin isoxazole derivatives with potent anti-cancer activity against breast cancer cell lines., 27 (18): [PMID:28838692] [10.1016/j.bmcl.2017.08.033] |
37. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek. (2020) Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection, [10.21203/rs.3.rs-23951/v1] |
38. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek. (2020) Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection, [10.21203/rs.3.rs-23951/v1] |
39. Liu J, Huang Z, Ma W, Peng S, Li Y, Miranda KM, Tian J, Zhang Y.. (2019) Design and synthesis of rosiglitazone-ferulic acid-nitric oxide donor trihybrids for improving glucose tolerance., 162 [PMID:30481687] [10.1016/j.ejmech.2018.10.006] |
40. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
41. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
42. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
43. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
44. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
45. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
46. Weng Z, Xu G, Chen D, Yang Y, Song G, Shen W, Zhang S, Wang L, Yang W, Zuo Z.. (2020) Discovery of a potent and selective adenylyl cyclase type 8 agonist by docking-based virtual screening., 30 (2): [PMID:31776060] [10.1016/j.bmcl.2019.126823] |
47. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
48. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius. (2021) HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators, [10.6019/CHEMBL4808148] |
49. Sutherland JJ, Yonchev D, Fekete A, Urban L.. (2023) A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs., 14 (1): [PMID:37468498] [10.1038/s41467-023-40064-9] |